The importance of lipid solubility in antioxidants and free radical generating systems for determining lipoprotein peroxidation

Free Radical Biology and Medicine

Volumn 26, Issue 11-12, 1999, Pages 1524-1530

  Massaeli, Hamid ^a,b   Sobrattee, Salisha ^a,b   Pierce, Grant N ^a,b  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Atherosclerosis; Coronary artery disease; Free radicals; Lazaroid; Lipid peroxidation; Low density lipoprotein; Oxygen derived free radicals; Trolox; Vitamin C; Vitamin E

Indexed keywords

2,2' AZOBIS(2 AMIDINOPROPANE); ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; AZO COMPOUND; FREE RADICAL; LAZAROID; LOW DENSITY LIPOPROTEIN; TROLOX C; VALERONITRILE;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; HEART PROTECTION; HYDROPHILICITY; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; LIPID SOLUBILITY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT; RISK FACTOR;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CHROMANS; FREE RADICALS; LIPID PEROXIDATION; LIPIDS; LIPOPROTEINS; MALE; RABBITS; SOLUBILITY; VITAMIN E; WATER;

ORYCTOLAGUS CUNICULUS;

EID: 0032968521     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(99)00018-0     Document Type: Article

References (30)

1. Goldstein J.L., Brown M.S. Regulation of low-density lipoprotein receptors implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis . Circulation. 76:1987;504-507.
2. Steinberg D., Witztum J.L. Lipoproteins and atherogenesis. Current concepts. JAMA. 264:1990;3047-3052.
3. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
4. Ylä-Herttuala, Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1989;1086-1095.
5. Parthasarathy S., Steinberg D., Witztum J.L. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu. Rev. Med. 43:1992;219-225.
6. Witztum J.L. Role of oxidised low density lipoprotein in atherogenesis. Br. Heart J. 69:1993;S12-S18.
7. Morel D.W., Hessler J.R., Chisolm G.M. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J. Lipid Res. 24:1983;1070-1076.
8. Parthasarathy S., Rankin S.M. Role of oxidized low density lipoprotein in atherogenesis. Prog. Lipid Res. 31:1992;127-143.
9. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13:1992;341-390.
10. Esterbauer, H.; Puhl, H.; Waeg, G.; Krebs, A.; Tatzber, F.; Rabl, H. Vitamin E and atherosclerosis: an overview. J. Nutr. Sci. Vitaminol. Tokyo. Spec No.:177-182; 1992.
11. Halliwell B., Gutteridge J.M.C. Role of free radicals and catalytic ions in human diseases. Packer L.S., Glazer A.N. Methods in Enzymology. 1990;1-85 Academic Press Inc, San Diego.
12. Niki E. Free radicals initiators as source of water- or lipid-soluble peroxyl radicals. Packer L.S., Glazer A.N. Methods in enzymology oxygen radicals in biological systems . 1990;100-108 Academic Press Inc, San Diego.
13. Liu K., Pierce G.N. The effects of low density lipoprotein on calcium transients in isolated rabbit cardiomyocytes. J. Biol. Chem. 268:1993;3767-3775.
14. Liu K., Massaeli H., Pierce G.N. The action of oxidized low density lipoprotein on calcium transients in isolated rabbit cardiomyocytes. J. Biol. Chem. 268:1993;4145-4151.
15. Mills G.L., Lane P.A., Weech P.K. Laboratory techniques in biochemistry and molecular biology. 1984;20-64 Elsevier Science Publisher, Netherlands.
16. Lowry O.H., Rosebrough N.J., Farr A.L., Randall A.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
17. Omodeo-Sale F., Marchesini S., Fishman P.H., Berra B. A sensitive enzymatic assay for determination of cholesterol in lipid extracts. Anal. Biochem. 142:1984;347-350.
18. Halliwell B., Chirico S. Lipid peroxidation its mechanism, measurement, and significance . Am. J. Clin. Nutr. 57:1993;715S-724S.
19. Milne D.B., Botnen J. Retinol, alpha-tocopherol, lycopene, and alpha- and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin. Chem. 32:1986;874-876.
20. Witztum J.L. Susceptibility of low-density lipoprotein to oxidative modification. Am. J. Med. 94:1993;347-349. [editorial; comment].
21. van Acker S.A., Koymans L.M., Bast A. Molecular pharmacology of vitamin E structural aspects of antioxidant activity . Free Radic. Biol. Med. 15:1993;311-328.
22. Suzuki Y.J., Tsuchiya M., Wassall S.R., Choo Y.M., Govil G., Kagan V.E., Packer L. Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol implication to the molecular mechanism of their antioxidant potency . Biochemistry. 32:1993;10692-10699.
23. Braughler J.M., Pregenzer J.F., Chase R.L., Duncan L.A., Jacobsen E.J., McCall J.M. Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J. Biol. Chem. 262:1987;10438-10440.
24. Braughler J.M., Burton P.S., Chase R.L., Pregenzer J.F., Jacobsen E.J., VanDoornik F.J., Tustin J.M., Ayer D.E., Bundy G.L. Novel membrane localized iron chelators as inhibitors of iron-dependent lipid peroxidation. Biochem. Pharmacol. 37:1988;3853-3860.
25. Niki, E. Antioxidants in relation to lipid peroxidation. In: Anonymous. Chemistry and Physics of Lipid. Ireland: Elsevier Scientific Publishers Ireland Ltd; 1987; 227-253.
26. Laughton M.J., Evans P.J., Moroney M.A., Hoult J.R., Halliwell B. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. Biochem. Pharmacol. 42:1991;1673-1681.
27. Rojas C., Cadenas S., Lopez T.M., Perez C.R., Barja G. Increase in heart glutathione redox ratio and total antioxidant capacity and decrease in lipid peroxidation after vitamin E dietary supplementation in guinea pigs. Free Radic. Biol. Med. 21:1996;907-915.
28. Diaz M.N., Frei B., Vita J.A., Keaney J.F.J. Antioxidants and atherosclerotic heart disease. N. Engl. J. Med. 337:1997;408-416.
29. Rimm E.B., Stampfer M.J. The role of antioxidants in preventive cardiology. Curr. Opin. Cardiol. 12:1997;188-194.
30. van de Vijver L., Kardinaal A.F., Grobbee D.E., Princen H.M., van Poppel G. Lipoprotein oxidation, antioxidants and cardiovascular risk epidemiologic evidence . Prostaglandins Leukot. Essent. Fatty Acids. 57:1997;479-487.